Premium
Measures of urine concentration in maternal urine screening for Down syndrome
Author(s) -
Iles R. K.,
Black A.,
Gunn L. K.,
Sehmi I. K.,
Cuckle H. S.,
Chard T.
Publication year - 1998
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/(sici)1097-0223(1998100)18:10<1006::aid-pd386>3.0.co;2-o
Subject(s) - urine , creatinine , urinary system , chemistry , gestation , urology , urine osmolality , chromatography , medicine , pregnancy , endocrinology , biology , genetics
A study was carried out to assess eight methods of normalizing the level of urinary β‐core human chorionic gonadotropin (hCG) for variable urine concentration. We compared the standard approach—creatinine determination by the Jaffe method—with high performance liquid chromatography (HPLC) measurement of creatinine, osmolarity and optical density at five wavelengths. Urine samples were included from a total of 472 women with unaffected singleton pregnancies at 15 weeks' gestation. The median β‐core hCG value was determined for each decile group when the results were ranked in turn according to the different measures of urine concentration. Creatinine using the Jaffe method had a much stronger relationship with median β‐core hCG than the other measures. Linear regression across the decile groups gave an R 2 value for Jaffe of 0·85 compared with HPLC of 0·53, osmolarity of 0·52, optical density at 405nm of 0·72, at 450nm of 0·57, at 490nm of 0·33, at 570nm of 0·34 and at 630nm of 0·33. We conclude that when screening with urinary β‐core hCG measuring creatinine appears to be an adequate method of allowing for variable urine concentration. Copyright © 1998 John Wiley & Sons, Ltd.